KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Rigel Pharmaceuticals (RIGL) Interest & Investment Income: 2009-2025

Historic Interest & Investment Income for Rigel Pharmaceuticals (RIGL) over the last 15 years, with Sep 2025 value amounting to $1.1 million.

  • Rigel Pharmaceuticals' Interest & Investment Income rose 157.41% to $1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.0 million, marking a year-over-year increase of 31.67%. This contributed to the annual value of $2.1 million for FY2024, which is 7.92% down from last year.
  • As of Q3 2025, Rigel Pharmaceuticals' Interest & Investment Income stood at $1.1 million, which was up 45.29% from $753,000 recorded in Q2 2025.
  • Over the past 5 years, Rigel Pharmaceuticals' Interest & Investment Income peaked at $1.1 million during Q3 2025, and registered a low of $1,000 during Q1 2021.
  • Moreover, its 3-year median value for Interest & Investment Income was $591,000 (2025), whereas its average is $618,364.
  • Per our database at Business Quant, Rigel Pharmaceuticals' Interest & Investment Income slumped by 99.72% in 2021 and then surged by 2,581.25% in 2022.
  • Over the past 5 years, Rigel Pharmaceuticals' Interest & Investment Income (Quarterly) stood at $16,000 in 2021, then skyrocketed by 2,581.25% to $429,000 in 2022, then spiked by 58.04% to $678,000 in 2023, then fell by 23.01% to $522,000 in 2024, then skyrocketed by 157.41% to $1.1 million in 2025.
  • Its Interest & Investment Income stands at $1.1 million for Q3 2025, versus $753,000 for Q2 2025 and $591,000 for Q1 2025.